HypErpolarised Xenon Magnetic Resonance PuLmonary Imaging in PAtIeNts with Long-COVID (EXPLAIN)

  • Funded by Department of Health and Social Care / National Institute for Health and Care Research (DHSC-NIHR)
  • Total publications:11 publications

Grant number: COV-LT2-0049

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2021
    2024
  • Known Financial Commitments (USD)

    $2,566,888.04
  • Funder

    Department of Health and Social Care / National Institute for Health and Care Research (DHSC-NIHR)
  • Principal Investigator

    N/A

  • Research Location

    United Kingdom
  • Lead Research Institution

    University of Oxford
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Disease pathogenesis

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

We wish to understand why some Long-COVID sufferers struggle with breathlessness on exertion and have a reduced ability to exercise. To do this, we will use MRI scanning and a special gas (hyperpolarised xenon) which is breathed in during the scan. The xenon gas is harmless in the quantity we use. This technique shows the movement of xenon within the lungs and moving out of the lungs into the bloodstream, similar to how oxygen is absorbed. The scans take about 15 minutes. In patients hospitalised with COVID-19, we found that scans several months after discharge showed evidence of persisting lung damage, even when other tests were normal. Importantly, on follow-up scanning, some have remained abnormal. We will use the same scan technique in Long-COVID sufferers not admitted to hospital, who have ongoing breathlessness on exertion to see if they have lung damage. If lung abnormalities are found, we will assess their severity and whether they improve over time. To do this, we will compare scans in the different groups of participants enabling us to see if their breathing problems are related to the lung damage. We will also include an MRI scan of the heart in some of the trial participants to see if the heart has also been damaged. If the Xenon MRI scans separate patients with and without lung disease, we will then analyse the CT scans using artificial intelligence and the blood samples to see if we can find associated abnormalities. We aim to provide a much-needed explanation to sufferers of Long-COVID struggling with breathlessness. Learning more about the nature of damage within the lungs through xenon MRI may help with the future development of treatments, and provide a reliable way of measuring lung damage changes over time.

Publicationslinked via Europe PMC

Last Updated:41 minutes ago

View all publications at Europe PMC

Evaluation of an integrated variable flip angle protocol to estimate coil B<sub>1</sub> for hyperpolarized MRI.

Age, sex, and lung volume dependence of dissolved xenon-129 MRI gas exchange metrics.

Longitudinal Lung Function Assessment of Patients Hospitalized With COVID-19 Using <sup>1</sup>H and <sup>129</sup>Xe Lung MRI.

Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post-COVID-19 Study.

Gas exchange and ventilation imaging of healthy and COPD subjects using hyperpolarized xenon-129 MRI and a 3D alveolar gas-exchange model.

Lung Abnormalities Detected with Hyperpolarized <sup>129</sup>Xe MRI in Patients with Long COVID.

Hyperpolarized Xenon MRI, Further Evidence of Its Use in Progressive Pulmonary Fibrosis?

Impaired pulmonary ventilation beyond pneumonia in COVID-19: A preliminary observation.

Hyperpolarized <sup>129</sup>Xe MRI Abnormalities in Dyspneic Patients 3 Months after COVID-19 Pneumonia: Preliminary Results.